ICE Bioscience Protein Science Platform offers integrated custom protein services, including cloning, expression, purification, quality control, and activity determination. The platform boasts over 1200 enzymatic assays, 700 target protein products, and more than 50 validated SPR assays, supporting new drug development for global partners.
Unlock the frontiers of drug discovery with ICE Bioscience, where our exceptional capabilities in GPCR drug discovery support you through every critical step, from target validation to the identification of pre-clinical candidates. Our comprehensive GPCR screening and assay development services are designed to accelerate innovations, supporting drug discovery teams in identifying and optimizing promising GPCR-targeted therapies.
With comprehensive capabilities spanning payload screening, in vitro and in vivo testing, and DMPK analysis, we ensure tailored solutions for optimizing ADCs at every stage of development. Our goal is to enhance therapeutic efficacy while minimizing off-target effects, driving innovation in next-generation oncology treatments.
ICE Bioscience offers comprehensive DMPK services to support drug discovery and development. We provide ADME profiling, metabolite identification, and tailored assays for small molecules, peptides, and biologics, ensuring high-quality data to optimize drug candidates' safety and efficacy.
